Some authors have proposed a potential role for CD34 antigen expression as an indicator of tumor aggressiveness, noting decreased or absent CD34 positivity in the stroma of invasive ductal breast carcinomas compared with in situ ductal carcinoma or normal skin [34,35,36]. Here, CD34 is linked to ductal breast carcinoma in situ.